Literature DB >> 21521337

Mutational analysis of RET proto-oncogene among patients with medullary thyroid carcinoma and 'at risk' carriers from India.

Rekha Pai, G Arun Nehru, Prasanna Samuel, M J Paul, Nihal Thomas, Jennifer Anne Premkumar, Julie Hephzibah, Nylla Shanthly, Regi Oommen, Aravindan Nair, M S Seshadri, Simon Rajaratnam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21521337     DOI： 10.1111/j.1365-2265.2011.04069.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  3 in total

1.  Outcome of Treatment for Medullary Thyroid Carcinoma-a Single Centre Experience.

Authors:  Anish Jacob Cherian; Pooja Ramakant; Rekha Pai; Marie Therese Manipadam; S Elanthenral; Anuradha Chandramohan; Julie Hephzibah; David Mathew; Dhukabandhu Naik; Thomas V Paul; Simon Rajaratnam; Nihal Thomas; M J Paul; Deepak Thomas Abraham
Journal:  Indian J Surg Oncol       Date:  2017-12-08

2.  A complex endocrine conundrum.

Authors:  G Bano; V Siedel; N Beharry; P Wilson; T Cranston; S Hodgson
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

3.  RET mutations in a large indian family with medullary thyroid carcinoma.

Authors:  D M Mahesh; Arun G Nehru; M S Seshadri; Nihal Thomas; Aravindan Nair; Rekha Pai; Simon Rajaratnam
Journal:  Indian J Endocrinol Metab       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.